Sh22,500.00
Bisoprolol, sold under the brand name “Concor” among others, is a medication belonging to the class of beta-blockers. It is commonly prescribed for various cardiovascular conditions.
Here are the main uses of Bisoprolol 10mg (Concor) tablets:
| Settings | BISOPROLOL 10MG CONCOR 30S remove | Ampiclox Capsules remove | Aciclovir Skin Cream remove | AMINOPHYLLINE INJECTION remove | ACTINAC PLUS TABS remove | OFLOX OZ 200\500 MG remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh22,500.00 | Sh10,000.00 | Sh2,000.00 | Sh1,500.00 | Sh4,000.00 | Sh7,000.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description | Bisoprolol, sold under the brand name "Concor" among others, is a medication belonging to the class of beta-blockers. It is commonly prescribed for various cardiovascular conditions. | Treats bacterial infections of the:
|
| Aminophylline injection is a type of medicine known as a bronchodilator, which is used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other conditions that affect the lungs and airways. | ||
| Content | Here are the main uses of Bisoprolol 10mg (Concor) tablets:
| AMPICLOX CAPSULE contains two antibiotics, namely: Ampicillin and Cloxacillin. AMPICLOX CAPSULE works by preventing the formation of bacterial cell covering, which is necessary for their survival. Thereby kills the bacteria and helps in treating and preventing bacterial infections | Aciclovir belongs to a class of medication known as antivirals. It works by stopping the growth of the virus. This medication does not cure herpes, and it does not prevent passing the infection to someone else. It does not prevent a future occurrence. | The main uses of Aminophylline injection include:
| It is used to reduce pain and inflammation in conditions like:
| Used to treat:
|
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.